Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Assessment of disease progression in dysferlinopathy: A 1-year cohort study.

Moore U, Jacobs M, James MK, Mayhew AG, Fernandez-Torron R, Feng J, Cnaan A, Eagle M, Bettinson K, Rufibach LE, Lofra RM, Blamire AM, Carlier PG, Mittal P, Lowes LP, Alfano L, Rose K, Duong T, Berry KM, Montiel-Morillo E, Pedrosa-Hernández I, Holsten S, Sanjak M, Ashida A, Sakamoto C, Tateishi T, Yajima H, Canal A, Ollivier G, Decostre V, Mendez JB, Sánchez-Aguilera Praxedes N, Thiele S, Siener C, Shierbecker J, Florence JM, Vandevelde B, DeWolf B, Hutchence M, Gee R, Prügel J, Maron E, Hilsden H, Lochmüller H, Grieben U, Spuler S, Tesi Rocha C, Day JW, Jones KJ, Bharucha-Goebel DX, Salort-Campana E, Harms M, Pestronk A, Krause S, Schreiber-Katz O, Walter MC, Paradas C, Hogrel JY, Stojkovic T, Takeda S, Mori-Yoshimura M, Bravver E, Sparks S, Díaz-Manera J, Bello L, Semplicini C, Pegoraro E, Mendell JR, Bushby K, Straub V; Jain COS Consortium.

Neurology. 2019 Jan 9. pii: 10.1212/WNL.0000000000006858. doi: 10.1212/WNL.0000000000006858. [Epub ahead of print]

2.

A Guide to Understanding the Benefits of a Multidisciplinary Team Approach to Amyotrophic Lateral Sclerosis (ALS) Treatment.

Driskell LD, York MK, Heyn PC, Sanjak M, MacAdam C.

Arch Phys Med Rehabil. 2019 Mar;100(3):583-586. doi: 10.1016/j.apmr.2018.05.002. Epub 2018 Jul 17. No abstract available.

PMID:
30029769
3.

A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis.

Clawson LL, Cudkowicz M, Krivickas L, Brooks BR, Sanjak M, Allred P, Atassi N, Swartz A, Steinhorn G, Uchil A, Riley KM, Yu H, Schoenfeld DA, Maragakis NJ; neals consortium.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):250-258. doi: 10.1080/21678421.2017.1404108. Epub 2017 Nov 30.

PMID:
29191052
4.

Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.

Sanjak M, Langford V, Holsten S, Rozario N, Patterson CGM, Bravver E, Bockenek WL, Brooks BR.

Arch Phys Med Rehabil. 2017 Nov;98(11):2301-2307. doi: 10.1016/j.apmr.2017.04.004. Epub 2017 Apr 30.

PMID:
28465220
5.

Exercise-induced neuroplasticity in human Parkinson's disease: What is the evidence telling us?

Hirsch MA, Iyer SS, Sanjak M.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S78-81. doi: 10.1016/j.parkreldis.2015.09.030. Epub 2015 Sep 15. Review.

PMID:
26439945
6.

Vestibular deficits leading to disequilibrium and falls in ambulatory amyotrophic lateral sclerosis.

Sanjak M, Hirsch MA, Bravver EK, Bockenek WL, Norton HJ, Brooks BR.

Arch Phys Med Rehabil. 2014 Oct;95(10):1933-9. doi: 10.1016/j.apmr.2014.05.024. Epub 2014 Jun 16.

PMID:
24946083
7.

Quality improvement in neurology: amyotrophic lateral sclerosis quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.

Miller RG, Brooks BR, Swain-Eng RJ, Basner RC, Carter GT, Casey P, Cohen AB, Dubinsky R, Forshew D, Jackson CE, Kasarskis E, Procaccini NJ, Sanjak M, Tolin FP.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):165-8. doi: 10.3109/21678421.2013.875706. Epub 2014 Apr 7. No abstract available.

PMID:
24707820
8.

Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology.

Miller RG, Brooks BR, Swain-Eng RJ, Basner RC, Carter GT, Casey P, Cohen AB, Dubinsky R, Forshew D, Jackson CE, Kasarskis E, Procaccini NJ, Sanjak M, Tolin FP.

Neurology. 2013 Dec 10;81(24):2136-40. doi: 10.1212/01.wnl.0000437305.37850.f9. Epub 2013 Nov 22. Review.

9.

Parkinson patients as partners in care.

Hirsch MA, Sanjak M, Englert D, Iyer S, Quinlan MM.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S174-9. doi: 10.1016/S1353-8020(13)70041-5.

PMID:
24262175
10.

Surgeon fatigue and postural stability: is robotic better than laparoscopic surgery?

Butler KA, Kapetanakis VE, Smith BE, Sanjak M, Verheijde JL, Chang YH, Magtibay PM, Magrina JF.

J Laparoendosc Adv Surg Tech A. 2013 Apr;23(4):343-6. doi: 10.1089/lap.2012.0531. Epub 2013 Feb 14.

PMID:
23410117
11.

Promoting exercise in Parkinson's disease through community-based participatory research.

Hirsch MA, Iyer SS, Englert D, Sanjak M.

Neurodegener Dis Manag. 2011 Oct;1(5):365-377.

12.

Supported treadmill ambulation for amyotrophic lateral sclerosis: a pilot study.

Sanjak M, Bravver E, Bockenek WL, Norton HJ, Brooks BR.

Arch Phys Med Rehabil. 2010 Dec;91(12):1920-9. doi: 10.1016/j.apmr.2010.08.009.

PMID:
21112435
13.

Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis.

Sanjak M, Salachas F, Frija-Orvoen E, Theys P, Hutchinson D, Verheijde J, Pianta T, Stewart H, Brooks BR, Meininger V, Douillet P; Xaliproden [SR57746A] ALS International Study Group.

Amyotroph Lateral Scler. 2010 Aug;11(4):383-8. doi: 10.3109/17482960903486083.

PMID:
20192884
14.

Power wheelchair prescription, utilization, satisfaction, and cost for patients with amyotrophic lateral sclerosis: preliminary data for evidence-based guidelines.

Ward AL, Sanjak M, Duffy K, Bravver E, Williams N, Nichols M, Brooks BR.

Arch Phys Med Rehabil. 2010 Feb;91(2):268-72. doi: 10.1016/j.apmr.2009.10.023.

PMID:
20159132
15.

Disease-modifying drug therapies.

Brooks BR, Sanjak M.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:68-75. No abstract available.

PMID:
15512878
16.

Dissociation between mechanical and myoelectrical manifestation of muscle fatigue in amyotrophic lateral sclerosis.

Sanjak M, Konopacki R, Capasso R, Roelke KA, Peper SM, Houdek AM, Waclawik A, Brooks BR.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Mar;5(1):26-32.

PMID:
15204021
17.

Measurement of strength: pro.

Sanjak M.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3 Suppl 1:S45-7. No abstract available.

PMID:
12396805
18.

Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis.

Sanjak M, Brinkmann J, Belden DS, Roelke K, Waclawik A, Neville HE, Ringel SP, Murphy JR, Brooks BR.

J Neurol Sci. 2001 Oct 15;191(1-2):55-9.

PMID:
11676992
19.

Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: beta-2 adrenergic agonists.

Brooks BR, Juhasz-Poscine K, Waclawik A, Sanjak M, Belden D, Roelke K, Parnell J, Weasler C.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1 Suppl 4:45-53; discussion 53-4. Review. No abstract available.

PMID:
11466959
20.

Quantitative assessment of motor fatigue and strength in MS.

Schwid SR, Thornton CA, Pandya S, Manzur KL, Sanjak M, Petrie MD, McDermott MP, Goodman AD.

Neurology. 1999 Sep 11;53(4):743-50.

PMID:
10489035

Supplemental Content

Loading ...
Support Center